$TDOC - On our watchlist/trading list. Good longer-term healthcare growth play.Teladoc initiated at RBC CapitalTeladoc initiated with an Outperform at RBC Capital. RBC Capital analyst Sean Dodge initiated coverage of Teladoc with an Outperform rating and price target. The company is "approaching its tipping point" as utilization should grow "significantly" over the coming years, Dodge tells investors in a research note. He calls Teladoc the market leader in virtual health with "durable" competitive advantages. The analyst estimates the U.S. total addressable market for general medical and behavioral health alone to be B per year, and says Teladoc is only ~5% penetrated. $TDOC, Teladoc Health, Inc. / H1 Disclosure: I may trade in the ticker symbols mentioned, both long or short. My articles represent my personal opinion and analysis and should not be taken as investment advice. Readers should do their own research before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal. If you liked this article, please click the LIKE (thumbs up) button. Feel free to leave any comments, question, or opinions. (Sign-up if you haven't already done so). Follow us/bookmark us and check back occasionally for additional articles or comments on our page... Wild Tiger Trading - start/main page